T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.4% |
| 2 | Healthcare | 16.1% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Performance Food Group
PFGC
$16.7B
| $30.1M | ﹤0.01% |
655,634
-514,247
| -44% | -$23.4M |
|
|
PCSB
1177
DELISTED
PCSB Financial Corporation
PCSB
| $30.1M | ﹤0.01% |
1,578,896
-21,539
| -1% | -$403K |
|
1178
Genuine Parts
GPC
$18.6B
| $30.1M | ﹤0.01% |
214,404
-7,643
| -3% | -$1.01M |
|
1179
Kimbell Royalty Partners
KRP
$1.54B
| $30M | ﹤0.01% |
2,200,685
| – | – |
|
1180
Blackbaud
BLKB
$2.08B
| $29.9M | ﹤0.01% |
378,379
-5,248
| -1% | -$405K |
|
1181
Moog Inc Class A
MOG.A
$13.9B
| $29.8M | ﹤0.01% |
367,867
-9,994
| -3% | -$775K |
|
1182
Cencora
COR
$59.1B
| $29.7M | ﹤0.01% |
223,607
-8,115
| -4% | -$998K |
|
1183
American Vanguard Corp
AVD
$63.7M
| $29.7M | ﹤0.01% |
1,810,260
-500
| -0% | -$7.83K |
|
1184
Aaon
AAON
$7.21B
| $29.6M | ﹤0.01% |
559,265
-59,236
| -10% | -$2.96M |
|
1185
Thryv Holdings
THRY
$96.4M
| $29.5M | ﹤0.01% |
716,903
-1,001,287
| -58% | -$34.5M |
|
|
NVTA
1186
DELISTED
Invitae Corporation
NVTA
| $29.3M | ﹤0.01% |
1,917,548
-571,320
| -23% | -$12.4M |
|
1187
Coastal Financial
CCB
$782M
| $29.3M | ﹤0.01% |
577,835
+515,477
| +827% | +$21.3M |
|
1188
Healthpeak Properties
DOC
$14.3B
| $29.2M | ﹤0.01% |
810,108
-28,398
| -3% | -$979K |
|
1189
Pegasystems
PEGA
$5.35B
| $29.2M | ﹤0.01% |
521,838
-174,568
| -25% | -$10.3M |
|
1190
Ameresco
AMRC
$1.51B
| $29.2M | ﹤0.01% |
358,028
-115,255
| -24% | -$9.22M |
|
1191
Privia Health
PRVA
$2.8B
| $28.9M | ﹤0.01% |
1,118,118
+469,625
| +72% | +$11.7M |
|
|
ABCM
1192
DELISTED
Abcam PLC
ABCM
| $28.4M | ﹤0.01% |
1,207,933
-40,223
| -3% | -$900K |
|
1193
Amcor
AMCR
$21.3B
| $28.3M | ﹤0.01% |
471,920
-20,620
| -4% | -$1.22M |
|
1194
iShares Russell 1000 Growth ETF
IWF
$129B
| $28.2M | ﹤0.01% |
369,384
+223,376
| +153% | +$16.6M |
|
1195
uniQure
QURE
$3.24B
| $28.2M | ﹤0.01% |
1,358,709
-243,457
| -15% | -$6.98M |
|
1196
Zymeworks
ZYME
$1.77B
| $28.1M | ﹤0.01% |
1,714,905
+17,592
| +1% | +$367K |
|
1197
Allegion
ALLE
$14B
| $27.9M | ﹤0.01% |
210,717
-10,382
| -5% | -$1.36M |
|
1198
Arch Capital
ACGL
$33.6B
| $27.6M | ﹤0.01% |
620,847
+426,218
| +219% | +$18.1M |
|
1199
Stoneridge
SRI
$204M
| $27.2M | ﹤0.01% |
1,378,278
-308,664
| -18% | -$6.52M |
|
1200
Clearway Energy Class C
CWEN
$7.08B
| $27.1M | ﹤0.01% |
752,032
-57,132
| -7% | -$2.02M |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.